Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Intratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid state.

Lundberg G, Jin Y, Sehic D, Øra I, Versteeg R, Gisselsson D.

PLoS One. 2013;8(3):e59268. doi: 10.1371/journal.pone.0059268. Epub 2013 Mar 21.

2.

Correlation between the number of segmental chromosome aberrations and the age at diagnosis of diploid neuroblastomas without MYCN amplification.

Souzaki R, Tajiri T, Teshiba R, Kinoshita Y, Yosue R, Kohashi K, Oda Y, Taguchi T.

J Pediatr Surg. 2011 Dec;46(12):2228-32. doi: 10.1016/j.jpedsurg.2011.09.005.

PMID:
22152855
3.

Binomial mitotic segregation of MYCN-carrying double minutes in neuroblastoma illustrates the role of randomness in oncogene amplification.

Lundberg G, Rosengren AH, Håkanson U, Stewénius H, Jin Y, Stewénius Y, Påhlman S, Gisselsson D.

PLoS One. 2008 Aug 29;3(8):e3099. doi: 10.1371/journal.pone.0003099.

4.
5.

Allelic imbalance on chromosome 5q predicts long-term survival in neuroblastoma.

Meltzer SJ, O'Doherty SP, Frantz CN, Smolinski K, Yin J, Cantor AB, Liu J, Valentine M, Brodeur GM, Berg PE.

Br J Cancer. 1996 Dec;74(12):1855-61.

6.
7.

Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene.

Djos A, Fransson S, Kogner P, Martinsson T.

BMC Med Genet. 2013 Oct 2;14:102. doi: 10.1186/1471-2350-14-102.

8.

cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma.

Chen QR, Bilke S, Wei JS, Whiteford CC, Cenacchi N, Krasnoselsky AL, Greer BT, Son CG, Westermann F, Berthold F, Schwab M, Catchpoole D, Khan J.

BMC Genomics. 2004 Sep 20;5:70.

9.

GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma.

Gumy-Pause F, Pardo B, Khoshbeen-Boudal M, Ansari M, Gayet-Ageron A, Sappino AP, Attiyeh EF, Ozsahin H.

Genes Chromosomes Cancer. 2012 Feb;51(2):174-85. doi: 10.1002/gcc.20941. Epub 2011 Nov 1.

PMID:
22045684
10.

Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.

Łastowska M, Viprey V, Santibanez-Koref M, Wappler I, Peters H, Cullinane C, Roberts P, Hall AG, Tweddle DA, Pearson AD, Lewis I, Burchill SA, Jackson MS.

Oncogene. 2007 Nov 22;26(53):7432-44. Epub 2007 May 28.

PMID:
17533364
11.

Genetic intratumour heterogeneity in high-grade brain tumours is associated with telomere-dependent mitotic instability.

Glanz C, Rebetz J, Stewénius Y, Persson A, Englund E, Mandahl N, Mertens F, Salford LG, Widegren B, Fan X, Gisselsson D.

Neuropathol Appl Neurobiol. 2007 Aug;33(4):440-54.

PMID:
17617873
12.

Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors.

Kryh H, Carén H, Erichsen J, Sjöberg RM, Abrahamsson J, Kogner P, Martinsson T.

BMC Genomics. 2011 Sep 7;12:443. doi: 10.1186/1471-2164-12-443.

13.

Accumulation of numerical and structural chromosome imbalances in spermatozoa from reciprocal translocation carriers.

Godo A, Blanco J, Vidal F, Anton E.

Hum Reprod. 2013 Mar;28(3):840-9. doi: 10.1093/humrep/des431. Epub 2012 Dec 18.

PMID:
23250926
14.
15.

Structural and numerical chromosome changes in colon cancer develop through telomere-mediated anaphase bridges, not through mitotic multipolarity.

Stewénius Y, Gorunova L, Jonson T, Larsson N, Höglund M, Mandahl N, Mertens F, Mitelman F, Gisselsson D.

Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5541-6. Epub 2005 Apr 4.

16.

PPM1D is a potential target for 17q gain in neuroblastoma.

Saito-Ohara F, Imoto I, Inoue J, Hosoi H, Nakagawara A, Sugimoto T, Inazawa J.

Cancer Res. 2003 Apr 15;63(8):1876-83.

17.

Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma.

Villamón E, Piqueras M, Mackintosh C, Alonso J, de Alava E, Navarro S, Noguera R.

Virchows Arch. 2008 Jul;453(1):47-55. doi: 10.1007/s00428-008-0633-6. Epub 2008 Jun 24.

PMID:
18574593
18.

Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization.

Beheshti B, Braude I, Marrano P, Thorner P, Zielenska M, Squire JA.

Neoplasia. 2003 Jan-Feb;5(1):53-62.

19.

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.

Carén H, Erichsen J, Olsson L, Enerbäck C, Sjöberg RM, Abrahamsson J, Kogner P, Martinsson T.

BMC Genomics. 2008 Jul 29;9:353. doi: 10.1186/1471-2164-9-353.

20.

Single nucleotide polymorphism array analysis to predict clinical outcome in neuroblastoma patients.

Hiyama E, Yamaoka H, Kamimatsuse A, Onitake Y, Hiyama K, Nishiyama M, Sueda T.

J Pediatr Surg. 2006 Dec;41(12):2032-6.

PMID:
17161199

Supplemental Content

Support Center